A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

ACCORIAN Joins Civitas Networks for Health

Accorian, today announced it has joined Civitas Networks for Health, the largest national network of its kind. Civitas is comprised of member organizations working to use health information exchange, health data, and multi-stakeholder, cross-sector approaches to improve health.

Accorian is a leader in providing cybersecurity and compliance services, with a special focus on the healthcare and health technology industry.

The company works with its clients to reduce their security risks and assist companies of all sizes to achieve their necessary cybersecurity compliance(s). As an external HITRUST assessor firm, and have helped companies achieve HITRUST certification along with SOC 2 and ISO certifications.

“With Accorian’s focus on heath, becoming a member of Civitas allows us to further that focus with the health collaboratives. We hope to continue working with HIEs to strengthen their security and compliance posture,” said Accorian CEO Premal Parikh.

Civitas Networks for Health is excited to have Accorian join our national network,” said Civitas CEO Lisa Bari. “We are raising the voices of local health collaboratives and those providing critical services to support health transformation. From the secure exchange of life-saving data to the accountability of multi-stakeholder initiatives, our member organizations have built the most trusted, connected, and inventive programs to serve their communities.”

SourceAccorian
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy